Cover Image

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria

Belen Sadaba, Jose Ramon Azanza, Almundena Gomez-Guiu, Raquel RodilClinical Pharmacology Service, Clinica Universidad de Navarra, Navarra, SpainAbstract: Bilastine is a second generation antihistamine indicated for the treatment of seasonal or perennial allergic rhinoconjunctivitis and chronic urtic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sadaba B (Author), Azanza JR (Author), Gomez-Guiu A (Author), Rodil R (Author)
Format:	Book
Published:	Dove Medical Press, 2013-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study
by: Giorgio Walter Canonica, et al.
Published: (2024)

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
by: Amalia Leceta, et al.
Published: (2017)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
by: Wang XY, et al.
Published: (2016)

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
by: Wai Kwong Cheong, et al.
Published: (2022)

Allergic Rhinoconjunctivitis: the Role of Histamine
by: M. Andersson, et al.
Published: (1994)

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine
by: R. Gerth van Wijk
Published: (1995)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
by: Staevska MT
Published: (2016)

Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis
by: Aranjit Singh Randhawa, et al.
Published: (2022)

Comparative clinical assessment of updosing of bilastine and combination of levocetirizine and hydroxyzine in chronic spontaneous urticaria
by: Bela Shah, et al.
Published: (2022)

Assessing serum cytokine and immunoglobulin levels in patients with allergic rhinitis and allergic rhinoconjunctivitis before and after treatment supplemented with macromycetes
by: V. K. Bogdanov, et al.
Published: (2023)

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
by: Rønborg SM, et al.
Published: (2012)

A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria
by: Boggarapu Sneha, et al.
Published: (2024)

Bilastine in Refractory Chronic Spontaneous Urticaria: Disease Control and Cytokine Modulation in an Open-label Prospective Study
by: Abhishek De, et al.
Published: (2024)

Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients
by: Abhishek De, et al.
Published: (2021)

Elucidation of Inverse Agonist Activity of Bilastine
by: Hiroyuki Mizuguchi, et al.
Published: (2020)

Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial
by: Gomes PJ, et al.
Published: (2018)

A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II
by: Gianluigi Marseglia, et al.
Published: (2019)

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
by: Shah B, et al.
Published: (2022)

Papules, pustules, and rhinoconjunctivitis in a 4-year-old
by: Amy G. Johnson, MD, et al.
Published: (2022)

Temporal trends in the prevalence of asthma and rhinoconjunctivitis in adolescents
by: Fernanda Agapito Pássaro Wilmer, et al.
Published: (2015)

Prevalence of COVID-19 in children affected by allergic rhinoconjunctivitis and asthma: results from the second "SIAIP rhinosinusitis and conjunctivitis committee" survey
by: Giulia Brindisi, et al.
Published: (2022)

Critical appraisal of Timothy grass pollen extract GRAZAX® in the management of allergic rhinitis
by: Scaparrotta A, et al.
Published: (2015)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
by: Michael Blaiss, et al.
Published: (2023)

A challenge for pediatrician: non allergic urticaria
by: M. Mandelli, et al.
Published: (2013)

Serum levels of Vitamin A and Atopic Rhinoconjunctivitis in Swedish adolescents
by: Malin Barman, et al.
Published: (2017)

Papain-induced occupational rhinoconjunctivitis and asthma - A case report
by: Diana Tymoszuk, et al.
Published: (2016)

Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions
by: Amalia Leceta, et al.
Published: (2021)

Design, Optimization and Characterization of Self-Nanoemulsifying Drug Delivery Systems of Bilastine
by: Ishraq Kadhim Abbas, et al.
Published: (2023)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
by: Yoshida H, et al.
Published: (2015)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
by: Carroll DG, et al.
Published: (2015)

EFFECTIVENESS OF SUBCUTANEOUS ALLERGEN-SPECIFIC IMMUNOTHERAPY WITH TREE POLLEN ALLERGEN EXTRACT ADSORBED ON CALCIUM PHOSPHATE IN CHILDREN WITH ALLERGIC RHINOCONJUNCTIVITIS: RESULTS OF A 2 YEAR-LONG OBSERVATION
by: N. V. Shakhova, et al.
Published: (2014)

Application of a dual mechanistic approach to support bilastine dose selection for older adults
by: Chaejin Kim, et al.
Published: (2021)

Incidence of allergic contact sensitization in central Chinese subjects with chronic urticaria
by: Hao Chen, et al.
Published: (2016)

A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
by: Francisco J.R. Paumgartten
Published: (2018)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
by: Nicolazzo D, et al.
Published: (2014)

Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia
by: Carpiniello B, et al.
Published: (2016)

Critical Appraisal of the AUGUSTUS Trial
by: Vineet Tatla, et al.
Published: (2020)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
by: Roberto Cesareo, et al.
Published: (2009)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
by: Linda L Hushaw, et al.
Published: (2010)

Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal
by: Chaouki K Khoury, et al.
Published: (2010)